Sign in to view content

Risk of Sight-Threatening Diabetic Retinopathy with GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes

Andrew J. Barkmeier, MD

Video
Published 2024

Related

Longitudinal Panretinal Leakage Index Assesment in Proliferative Diabetic Retinopathy Treated With Aflibercept From the RECOVERY Study
Amy S. Babiuch, MD, FASRS
Annual Meeting Talks
2019
ASRS Updates in the Management of Diabetic Retinopathy DME and PDR in the Middle East and Africa
Sunir J. Garg, MD, FACS, FASRS
Webinars and Journal Clubs
2023
Artificial Intelligence Screening for Diabetic Retinopathy: Subgroup Comparison of the EyeArt System with Ophthalmologists' Dilated Exams
Jennifer I. Lim, MD, FARVO, FASRS
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more